Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets

Published - Jun 2019| Code - HLC176C| Analyst - Vijay Laxmi

Report Highlights

The global radiopharmaceutical and therapeutics market should reach $22.0 billion by 2023 from $14.1 billion in 2018 at a compound annual growth rate (CAGR) of 9.2% for the period of 2018 to 2023.

Report Includes

  • 94 data tables and 83 additional tables
  • An overview of the global market for radiotherapy, radiopharmaceuticals and nuclear medicines
  • Examination of present and future strategies within the radiopharmaceuticals market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
  • Detailed description of positron emission tomography (PET) and single photon emission computed tomography (SPECT) and discussion of their applications
  • Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
  • Coverage of new products launches and product enhancement in the industry
  • Comprehensive company profiles of major players, including Accuray Inc., Bayer Pharma AG, C. R. Bard Inc., Eli Lilly and Company, Navidea Biopharmaceuticals Inc., Siemens Healthcare, and Triad Isotopes Inc.

Report Scope

The scope of this report is broad and covers type, production method, technology and applications of radiopharmaceuticals and therapeutics. By type, the market has been segmented into radiotherapy and radiopharmaceuticals. Revenue forecasts from 2017 to 2023 are provided for each segment and regional market, with estimated values derived from manufacturers’ total revenues.

The report also includes a discussion of the major players in each region in the radiopharmaceutical and therapeutics market. Further, it explains the major drivers and regional dynamics of the global radiopharmaceutical and therapeutics market and current trends within the industry.

The report concludes with a special focus on the vendor landscape and detailed profiles of the major vendors in this market.

Analyst Credentials

Vijay Laxmi has more than 20 years of experience in the healthcare domain. In addition to producing business research and consulting, she has conducted corporate briefings for top players in a wide range of market segments. She has worked with major market research firms and handled projects for various consultancies. Her market research studies include reports on:

  • Various medical device markets.
  • High-growth and niche markets in healthcare and life sciences.
  • Home healthcare market.
  • Medical tourism.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
Title/Chapter Name Pages Price Member Price
Full Report: Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets 232 $5,500 Free
Chapter- 1: Introduction7Free DownloadFree
Chapter- 2: Executive Summary3$250Free
Chapter- 3: Market Overview27$640Free
Chapter- 4: Market Dynamics23$545Free
Chapter- 5: Global Radiopharmaceutical and Therapeutics Market by Type32$759Free
Chapter- 6: Global Radiopharmaceutical and Therapeutics Market by Production Method8$190Free
Chapter- 7: Global Radiopharmaceutical and Therapeutics Market by Technology23$545Free
Chapter- 8: Global Radiopharmaceutical and Therapeutics Market by Application22$522Free
Chapter- 9: Geographic Analysis29$688Free
Chapter- 10: Industry Structure4$95Free
Chapter- 11: New Development and Current Situation13$308Free
Chapter- 12: Patent Analysis7$166Free
Chapter- 13: Competitive Landscape4$95Free
Chapter- 14: Company Profiles30$711Free
 
Published - Jun-2017| Analyst - Neha Maliwal| Code - HLC176B

Report Highlights

The global radiotherapy market was valued at $6.4 billion in 2016. The market should reach $6.8 billion and $9.2 billion in 2017 and 2022, respectively; growing at a compound annual growth rate (CAGR) of 6.4% from 2017 to 2022.

Report Includes

  • An overview of the global market for radiotherapy and related technologies and applications.
  • Analyses of market trends with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Discussion of major factors driving the growth for nuclear medicine, including neurological diseases such as Alzheimer's disease, Parkinson's disease, and dementia, and an overall increase in awareness about nuclear medicine.
  • Detailed information concerning major challenges the market faces, including the harmful effects of radiation, the tight required regulation of radioisotopes, and a lack of supply of radioisotopes.
  • Analyses of the diagnostic applications for radiotherapy, such as Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET).
  • Comprehensive company profiles of major players in the industry.
Published - Feb-2015| Analyst - Neha Maliwal| Code - HLC176A

Report Highlights

The radiation therapy market totaled $5.4 billion in 2013 and $5.8 billion in  2014. The market is expected to reach $8.1 billion in 2019, a compound annual growth rate(CAGR) of 6.7%. 

Report Includes

  • An overview of the global market for radiotherapy and related technologies and applications
  • Analyses of market trends, with data from 2013 and 2014, and projections of CAGRs through 2019
  • Discussion of major factors driving the growth for nuclear medicine including neurological diseases such as Alzheimer's disease, Parkinson's disease, and dementia, and an overall increase in awareness about nuclear medicine
  • Detailed information conerning major challenges the market faces including the harmful effects of radiation, the tight required regulation of radioisotopes, and a lack of supply of radioisotopes
  • Analysis of the diagnostic applications for radiotherapy such as Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET)
  • Comprehensive company profiles of major players in the industry.

RELATED REPORTS
Share This Report